\-\ Texto\\:\\ \ \(0\)\
\-\ epstein\\-barr\\ virus\\ igg\\ positive\\ with\\ titers\\ \\>1\\:2560\ \(0\)\
\-\ epstein\\-barr\\ virus\\ igm\\ negative\\	\ \(0\)\
\-\ heterophile\\ antibody\\ positive\ \(0\)\
\-\ he\\ was\\ treated\\ with\\ external\\ beam\\ radiation\\ therapy\\.\ \(0\)\
\-\ axial\\ ct\\ through\\ level\\ of\\ nasopharynx\ \(0\)\
\-\ asymmetry\\ of\\ the\\ soft\\ tissues\\ with\\ slight\\ increase\\ in\\ attenuation\\ in\\ the\\ left\\ lateral\\ nasopharyngeal\\ recess\\ \\(aka\\ fossa\\ of\\ rosenmuller\\)\ \(0\)\
\-\ well\\ circumscribed\\ hyperattenuated\\ soft\\ tissue\\ mass\\ in\\ location\\ of\\ lymph\\ nodes\\ \\(node\\ of\\ rouvierre\\)\ \(0\)\
\-\ axial\\ ct\\ through\\ level\\ of\\ nasopharynx\ \(0\)\
\-\ obliteration\\ of\\ the\\ normal\\ fat\\ planes\\ in\\ the\\ pterygopalatine\\ fossa\ \(0\)\
\-\ sagittal\\ t1\\ at\\ midline\ \(0\)\
\-\ nasopharyngeal\\ fullness\\,\\ convex\\ rather\\ than\\ concave\\ toward\\ brain\ \(0\)\
\-\ replacement\\ of\\ normal\\ t1\\-bright\\ marrow\\ signal\\ in\\ clivus\ \(0\)\
\-\ some\\ opacification\\ of\\ the\\ sphenoid\\ sinus\ \(0\)\
\-\ sagittal\\ t1\\ at\\ midline\ \(0\)\
\-\ sphenoid\\ opacified\ \(0\)\
\-\ posterior\\ to\\ maxilla\\ and\\ anterior\\ to\\ sphenoid\\ bone\\ is\\ pterygopalatine\\ fossa\\,\\ which\\ appears\\ to\\ be\\ full\\ of\\ a\\ soft\\ tissue\\ density\\ \ \(0\)\
\-\ able\\ to\\ see\\ foramen\\ rotundum\\,\\ widened\\ with\\ mass\\ filling\\ foramen\\ \ \(0\)\
\-\ axial\\ t2\\ through\\ the\\ level\\ of\\ the\\ orbits\ \(0\)\
\-\ sphenoid\\ is\\ opacified\\ with\\ t2\\ bright\\ signal\\,\\ consistent\\ with\\ mucus\\ secondary\\ to\\ mass\\ blocking\\ outflow\\ of\\ sinus\ \(0\)\
\-\ axial\\ spgr\\ fat\\-saturated\\ post\\-contrast\\ \\(t1\\ spin\\ gradient\\ technique\\)\ \(0\)\
\-\ enlarged\\ and\\ enhancing\\ nodes\\ of\\ left\\ anterior\\ cervical\\ chain\\ and\\ skull\\ base\\,\\ including\\ node\\ of\\ rouvierre\ \(0\)\
\-\ coronal\\ t1\\ post\\-gadolinium\\ fat\\-saturated\\ at\\ the\\ nasopharynx\ \(0\)\
\-\ can\\ see\\ extension\\ through\\ foramen\\ ovale\ \(0\)\
\-\ some\\ enhancing\\ opacification\\ of\\ inferior\\ sphenoid\\ sinus\ \(0\)\
\-\ loss\\ of\\ fat\\ planes\\ in\\ area\\ of\\ levator\\/tensor\\ veli\\ palatini\\ and\\ pterygoid\\ muscles\ \(0\)\
\-\ nasopharyngeal\\ carcinoma\ \(1\)\
\-\ nasopharyngeal\\ tumors\\ \\(e\\.g\\.\\,\\ squamous\\ cell\\ carcinoma\\,\\ nasopharyngeal\\ carcinoma\\,\\ lymphoma\\,\\ minor\\ salivary\\ gland\\ tumor\\,\\ rhabdomyosarcoma\\,\\ juvenile\\ angiofibroma\\)\ \(0\)\
\-\ malignant\\ ottitis\\ externa\ \(0\)\
\-\ benign\\ adenoidal\\ hypertrophy\ \(0\)\
\-\ abscess\ \(594\)\
\-\ mucocele\ \(25\)\
\-\ nasal\\ polyps\ \(1\)\
\-\ 35\\ yo\\ korean\\ man\\ with\\ a\\ 4\\.5\\ month\\ history\\ of\\ left\\ cervical\\ lymphadenopathy\\ not\\ responsive\\ to\\ antibiotics\\.\\ \\ the\\ patient\\ also\\ reports\\ a\\ 6\\ week\\ history\\ of\\ left\\ facial\\ parasthesias\\ and\\ occasional\\ left\\ sided\\ epistaxis\\ and\\ sinusitis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nasopharyngeal\\:\\ 0\\.0573401290264871\ \(0\)\
\-\ \\-epstein\\-barr\\:\\ 0\\.05687431241268709\ \(0\)\
\-\ rouvierre\\:\\ 0\\.05687431241268709\ \(0\)\
\-\ \\-nasopharyngeal\\:\\ 0\\.05687431241268709\ \(0\)\
\-\ \\-sphenoid\\:\\ 0\\.05687431241268709\ \(0\)\
\-\ nasopharynx\\:\\ 0\\.05681689785290379\ \(0\)\
\-\ \\-some\\:\\ 0\\.05240239511875196\ \(0\)\
\-\ pterygopalatine\\:\\ 0\\.047930477824816825\ \(0\)\
\-\ sphenoid\\:\\ 0\\.04601685883954915\ \(0\)\
\-\ fat\\-saturated\\:\\ 0\\.041404020330116954\ \(0\)\
\-\ foramen\\:\\ 0\\.03947729008618067\ \(0\)\
\-\ opacified\\:\\ 0\\.037877931901935856\ \(0\)\
\-\ virus\\:\\ 0\\.03610737160708579\ \(0\)\
\-\ t1\\:\\ 0\\.03494832949966766\ \(0\)\
\-\ fossa\\:\\ 0\\.03370451255517222\ \(0\)\
\-\ planes\\:\\ 0\\.03163545431315066\ \(0\)\
\-\ axial\\:\\ 0\\.03146827711055318\ \(0\)\
\-\ through\\:\\ 0\\.03131557443123702\ \(0\)\
\-\ sinus\\:\\ 0\\.03024347389976553\ \(0\)\
\-\ opacification\\:\\ 0\\.029193928921407146\ \(0\)\
\-\ 1\\:2560\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ \\-heterophile\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ \\-asymmetry\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ hyperattenuated\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ \\-replacement\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ \\-able\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ \\-can\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ levator\\/tensor\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ palatini\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ ottitis\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ adenoidal\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ \\-mucocele\\:\\ 0\\.028437156206343545\ \(0\)\
\-\ \\-well\\:\\ 0\\.02620119755937598\ \(0\)\
\-\ \\-obliteration\\:\\ 0\\.02620119755937598\ \(0\)\
\-\ spgr\\:\\ 0\\.02620119755937598\ \(0\)\
\-\ \\-loss\\:\\ 0\\.02620119755937598\ \(0\)\
\-\ \\-malignant\\:\\ 0\\.02620119755937598\ \(0\)\
\-\ node\\:\\ 0\\.025227378358245605\ \(0\)\
\-\ nodes\\:\\ 0\\.024901234621711208\ \(0\)\
\-\ rosenmuller\\:\\ 0\\.024893245597736736\ \(0\)\
\-\ \\-enlarged\\:\\ 0\\.024893245597736736\ \(0\)\
\-\ externa\\:\\ 0\\.024893245597736736\ \(0\)\
\-\ \\-nasal\\:\\ 0\\.024893245597736736\ \(0\)\
\-\ t1\\-bright\\:\\ 0\\.023965238912408413\ \(0\)\
\-\ \\-posterior\\:\\ 0\\.023965238912408413\ \(0\)\
\-\ rotundum\\:\\ 0\\.023965238912408413\ \(0\)\
\-\ veli\\:\\ 0\\.023965238912408413\ \(0\)\
\-\ \\-benign\\:\\ 0\\.023965238912408413\ \(0\)\
\-\ level\\:\\ 0\\.02383440994497031\ \(0\)\
\-\ carcinoma\\:\\ 0\\.023438009709830968\ \(0\)\
\-\ korean\\:\\ 0\\.023245421004943218\ \(0\)\
\-\ blocking\\:\\ 0\\.02265728695076917\ \(0\)\
\-\ \\-abscess\\:\\ 0\\.02265728695076917\ \(0\)\
\-\ parasthesias\\:\\ 0\\.022160026693261888\ \(0\)\
\-\ sagittal\\:\\ 0\\.021989333241976643\ \(0\)\
\-\ titers\\:\\ 0\\.021729280265440847\ \(0\)\
\-\ pterygoid\\:\\ 0\\.02134933498912993\ \(0\)\
\-\ midline\\:\\ 0\\.021329871531216262\ \(0\)\
\-\ ovale\\:\\ 0\\.020421328303801604\ \(0\)\
\-\ igm\\:\\ 0\\.020163126020983746\ \(0\)\
\-\ concave\\:\\ 0\\.020163126020983746\ \(0\)\
\-\ soft\\:\\ 0\\.020138000941873065\ \(0\)\
\-\ cervical\\:\\ 0\\.02003284778446212\ \(0\)\
\-\ angiofibroma\\:\\ 0\\.019924068046294322\ \(0\)\
\-\ epistaxis\\:\\ 0\\.019924068046294322\ \(0\)\
\-\ e\\.g\\.\\:\\ 0\\.019701510396336414\ \(0\)\
\-\ aka\\:\\ 0\\.01949332161847328\ \(0\)\
\-\ igg\\:\\ 0\\.018938965950967928\ \(0\)\
\-\ maxilla\\:\\ 0\\.018773503711008086\ \(0\)\
\-\ beam\\:\\ 0\\.01861611608465508\ \(0\)\
\-\ recess\\:\\ 0\\.01861611608465508\ \(0\)\
\-\ convex\\:\\ 0\\.01861611608465508\ \(0\)\
\-\ clivus\\:\\ 0\\.01861611608465508\ \(0\)\
\-\ chain\\:\\ 0\\.01861611608465508\ \(0\)\
\-\ salivary\\:\\ 0\\.01861611608465508\ \(0\)\
\-\ 4\\.5\\:\\ 0\\.01861611608465508\ \(0\)\
\-\ mucus\\:\\ 0\\.01846605151809091\ \(0\)\
\-\ antibody\\:\\ 0\\.01832265873560435\ \(0\)\
\-\ outflow\\:\\ 0\\.01832265873560435\ \(0\)\
\-\ responsive\\:\\ 0\\.01832265873560435\ \(0\)\
\-\ orbits\\:\\ 0\\.01792716737401618\ \(0\)\
\-\ spin\\:\\ 0\\.01792716737401618\ \(0\)\
\-\ positive\\:\\ 0\\.017889584453445913\ \(0\)\
\-\ post\\-contrast\\:\\ 0\\.0173597781273592\ \(0\)\
\-\ enhancing\\:\\ 0\\.017290022792804897\ \(0\)\
\-\ post\\-gadolinium\\:\\ 0\\.01715809955645167\ \(0\)\
\-\ fat\\:\\ 0\\.0167671762766557\ \(0\)\
\-\ gradient\\:\\ 0\\.016703007304000362\ \(0\)\
\-\ polyps\\:\\ 0\\.016703007304000362\ \(0\)\
\-\ see\\:\\ 0\\.01645301426599218\ \(0\)\
\-\ widened\\:\\ 0\\.016380157437687514\ \(0\)\
\-\ sinusitis\\:\\ 0\\.015949411009866476\ \(0\)\
\-\ technique\\:\\ 0\\.015882897180180232\ \(0\)\
\-\ fullness\\:\\ 0\\.015753847713684425\ \(0\)\
\-\ toward\\:\\ 0\\.015691208727048614\ \(0\)\
\-\ t2\\:\\ 0\\.015603798508066787\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.015510274963658153\ \(0\)\
\-\ left\\:\\ 0\\.015421052730208301\ \(0\)\
\-\ juvenile\\:\\ 0\\.015021404324538148\ \(0\)\
\-\ occasional\\:\\ 0\\.01455307526052364\ \(0\)\
\-\ signal\\:\\ 0\\.014535963421114701\ \(0\)\
\-\ anterior\\:\\ 0\\.014198663379114435\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.014182831665064193\ \(0\)\
\-\ minor\\:\\ 0\\.014144198790719948\ \(0\)\
\-\ bright\\:\\ 0\\.013781366586117724\ \(0\)\
\-\ squamous\\:\\ 0\\.01348641753463504\ \(0\)\
\-\ rather\\:\\ 0\\.01310299429954882\ \(0\)\
\-\ tissue\\:\\ 0\\.013067233473887701\ \(0\)\
\-\ slight\\:\\ 0\\.01296686412377341\ \(0\)\
\-\ 35\\:\\ 0\\.01268618226251654\ \(0\)\
\-\ muscles\\:\\ 0\\.012589882381388537\ \(0\)\
\-\ circumscribed\\:\\ 0\\.012252382539198624\ \(0\)\
\-\ marrow\\:\\ 0\\.01212668586651029\ \(0\)\
\-\ facial\\:\\ 0\\.011985974181104192\ \(0\)\
\-\ full\\:\\ 0\\.011908240143752384\ \(0\)\
\-\ skull\\:\\ 0\\.01173989900449248\ \(0\)\
\-\ gland\\:\\ 0\\.01173989900449248\ \(0\)\
\-\ external\\:\\ 0\\.011721725398949721\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.011721725398949721\ \(0\)\
\-\ increase\\:\\ 0\\.011562612281006166\ \(0\)\
\-\ mass\\:\\ 0\\.011501235551105464\ \(0\)\
\-\ coronal\\:\\ 0\\.011477493715931344\ \(0\)\
\-\ tissues\\:\\ 0\\.011313712021178365\ \(0\)\
\-\ at\\:\\ 0\\.011204159543531933\ \(0\)\
\-\ lymph\\:\\ 0\\.011127556157885956\ \(0\)\
\-\ reports\\:\\ 0\\.011112517405931728\ \(0\)\
\-\ filling\\:\\ 0\\.011097548439620429\ \(0\)\
\-\ attenuation\\:\\ 0\\.011082648614277544\ \(0\)\
\-\ base\\:\\ 0\\.010798252525262474\ \(0\)\
\-\ tumors\\:\\ 0\\.010353923734420971\ \(0\)\
\-\ antibiotics\\:\\ 0\\.010353923734420971\ \(0\)\
\-\ appears\\:\\ 0\\.010260415550958867\ \(0\)\
\-\ sided\\:\\ 0\\.010192021332731114\ \(0\)\
\-\ including\\:\\ 0\\.00995296335804169\ \(0\)\
\-\ extension\\:\\ 0\\.009839765552198882\ \(0\)\
\-\ location\\:\\ 0\\.009615186086786753\ \(0\)\
\-\ \\,\\:\\ 0\\.009605841034484391\ \(0\)\
\-\ week\\:\\ 0\\.009361340059123317\ \(0\)\
\-\ inferior\\:\\ 0\\.009352633423738913\ \(0\)\
\-\ \\(\\:\\ 0\\.009320796467662717\ \(0\)\
\-\ \\)\\:\\ 0\\.009206937962752324\ \(0\)\
\-\ \\>\\:\\ 0\\.009158604886027627\ \(0\)\
\-\ density\\:\\ 0\\.009069778570515998\ \(0\)\
\-\ radiation\\:\\ 0\\.00904597177278173\ \(0\)\
\-\ area\\:\\ 0\\.008715600787529894\ \(0\)\
\-\ normal\\:\\ 0\\.008642660997413554\ \(0\)\
\-\ brain\\:\\ 0\\.008294682333234715\ \(0\)\
\-\ yo\\:\\ 0\\.008294682333234715\ \(0\)\
\-\ month\\:\\ 0\\.008269724325163257\ \(0\)\
\-\ to\\:\\ 0\\.008265834356961025\ \(0\)\
\-\ treated\\:\\ 0\\.008251131729302771\ \(0\)\
\-\ negative\\:\\ 0\\.008232645681854433\ \(0\)\
\-\ 6\\:\\ 0\\.008232645681854433\ \(0\)\
\-\ in\\:\\ 0\\.008156075422069451\ \(0\)\
\-\ lymphoma\\:\\ 0\\.007878060110933826\ \(0\)\
\-\ ct\\:\\ 0\\.0077116364734970515\ \(0\)\
\-\ secondary\\:\\ 0\\.007706548279060669\ \(0\)\
\-\ he\\:\\ 0\\.007690926909783934\ \(0\)\
\-\ history\\:\\ 0\\.007614287340045699\ \(0\)\
\-\ cell\\:\\ 0\\.007445937779295117\ \(0\)\
\-\ therapy\\:\\ 0\\.0073698090201310094\ \(0\)\
\-\ than\\:\\ 0\\.007222738241671851\ \(0\)\
\-\ of\\:\\ 0\\.0071405555327799354\ \(0\)\
\-\ bone\\:\\ 0\\.006849789295031839\ \(0\)\
\-\ consistent\\:\\ 0\\.006759026673649042\ \(0\)\
\-\ man\\:\\ 0\\.006519134977709675\ \(0\)\
\-\ tumor\\:\\ 0\\.006426555811647778\ \(0\)\
\-\ lateral\\:\\ 0\\.005956993695563065\ \(0\)\
\-\ also\\:\\ 0\\.005434256753774682\ \(0\)\
\-\ which\\:\\ 0\\.0051456277007824154\ \(0\)\
\-\ be\\:\\ 0\\.004250828139819126\ \(0\)\
\-\ the\\:\\ 0\\.004013688910750427\ \(0\)\
\-\ not\\:\\ 0\\.003983286037877211\ \(0\)\
\-\ a\\:\\ 0\\.0038380625982445287\ \(0\)\
\-\ is\\:\\ 0\\.003627682441191778\ \(0\)\
\-\ and\\:\\ 0\\.0034840452722364862\ \(0\)\
\-\ was\\:\\ 0\\.003187992007140925\ \(0\)\
\-\ patient\\:\\ 0\\.0027631997771496385\ \(0\)\
\-\ with\\:\\ 0\\.0026420297826749294\ \(0\)\
\-\ \\.\\:\\ 0\\.0003435438977162543\ \(0\)\
